PLATT DAVID 4
4 · BIOXYTRAN, INC · Filed May 17, 2023
Insider Transaction Report
Form 4
BIOXYTRAN, INCBIXT
PLATT DAVID
DirectorCEO10% Owner
Transactions
- Gift
common
2023-05-17$0.32/sh−92,000$29,440→ 19,535,300 total(indirect: by NDPD Pharma, Inc.)
Footnotes (1)
- [F1]The total holdings in BIXT by NDPD Pharma, Inc., partly owned by officers of BIXT, are consolidated under indirect ownership in Davis Platt's filing.